Bioethics News

‘Right to Try’ Is a Sham

Richard Plotkin writes: “Congress is considering “Right to Try” (RTT) bills related to the use of unapproved medical products by patients diagnosed with a terminal illness. In essence, these bills seek to remove the use of experimental medical products outside of clinical trials from the oversight of the Food and Drug Administration (FDA) based on the false claim that the FDA moves too slowly….”

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.